MOXIFLOXACINE VIATRIS 400 mg, film-coated tablet 5 tablets, CIP 3400927855252
Active ingredients: Moxifloxacin hydrochloride, Moxifloxacin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet5 tablets, CIP 3400927855252orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOXIFLOXACINE VIATRIS 400 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 5 plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 1 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 18 Jul 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66862471CIP72785525CIP133400927855252Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MOXIFLOXACINEcomprimé | 400 mg · un comprimé | FT |
| CHLORHYDRATE DE MOXIFLOXACINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.